Administration of stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) (SCF+G-CSF) has shown increases of dendritic density, dendritic spines, and synapses in the peri-infarct cortex and improvements of functional outcomes after experimental stroke [9, 25]. This evidence concerns the gene CSF3 and stroke disorder.